asp0367
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 31, 2020 (NCT04184882)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cnc(-c2ccc(C(F)(F)F)cc2)n1Cc1ccccc1OCCC[C@@H](C)CC(=O)O- Mol. weight
- 460.5 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095171 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05217901 | Phase 1 | Jan 22, 2022 | Astellas |
| NCT05117294 | Phase 1 | Nov 30, 2021 | Astellas |
| NCT04942964 | Phase 1 | Jul 21, 2021 | Astellas |
| NCT04855201 | Phase 1 | May 27, 2021 | Astellas |
| NCT04641962 | Phase 2/Phase 3 (Phase 3) | Feb 28, 2021 | Astellas |
| NCT04184882 | Phase 1 | Jan 31, 2020 | Astellas |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 6 | 6 | 2 | 2020 |
1 organizations
Page 1 / 1